Table 5 Exposure to Wazazi Nipendeni (number of message sources) and its association with study outcomes
Predictor | B | SE B | 95% CIs | p | β | OR |
|---|---|---|---|---|---|---|
Unadjusted | ||||||
Birth planning | 0.09 | 0.02 | 0.05 – 0.14 | <.001 | .10 | -- |
First antenatal visit during 1st trimester | 0.03 | 0.03 | 0.98 – 1.09 | .26 | -- | 1.03 |
Number of antenatal visits before delivery | 0.06 | 0.02 | 0.02 - 0.09 | .002 | .08 | -- |
Delivery at a health care facility | 0.13 | 0.07 | 1.00 – 1.31 | .05 | -- | 1.14 |
HIV testing (self) | 0.07 | 0.06 | 0.95 – 1.22 | .24 | -- | 1.08 |
HIV testing with partner | 0.09 | 0.03 | 0.98 – 1.18 | .05 | -- | 1.09 |
Adjusted with covariates | ||||||
Birth planning | 0.08 | 0.02 | 0.03 – 0.12 | .001 | .09 | -- |
First antenatal visit during 1st trimester | 0.02 | 0.03 | 0.96 - 1.08 | .62 | -- | 1.02 |
Number of antenatal visits before delivery | 0.05 | 0.02 | 0.02 - 0.09 | .004 | .07 | -- |
Delivery at a health care facility | 0.08 | 0.07 | 0.94 – 1.25 | .28 | -- | 1.08 |
HIV testing (self) | 0.07 | 0.07 | 0.93 – 1.22 | .34 | -- | 1.07 |
HIV testing with partner | 0.05 | 0.05 | 0.96 – 1.15 | .30 | -- | 1.05 |